Prometheus Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
146.18
|
|
Average Rating
|
4.64
|
|
# Strong Buys
|
7
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.88
|
0.00
|
0.88
|
100.00%
|
|
2022-12-31
|
-0.90
|
0.00
|
0.90
|
100.00%
|
|
2022-09-30
|
-0.90
|
-0.90
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.91
|
-0.86
|
0.05
|
5.49%
|
|
2022-03-31
|
-0.79
|
-0.82
|
-0.03
|
-3.80%
|
|
2021-12-31
|
-0.68
|
-0.77
|
-0.09
|
-13.24%
|
|
2021-09-30
|
-0.59
|
-0.70
|
-0.11
|
-18.64%
|
|
2021-06-30
|
-0.39
|
-0.49
|
-0.10
|
-25.64%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.58
|
|
2021-12-31
|
-3.63
|